Clinical Trials Logo
NCT number NCT03189901
Study type Interventional
Source Qilu Hospital of Shandong University
Contact Feng Xu, M.D.
Phone +86-18560083066
Email xufengsdu@126.com
Status Recruiting
Phase Phase 4
Start date July 1, 2017
Completion date July 1, 2018

Clinical Trial Summary

There are always poor outcomes in patients with acute myocardial infarction(AMI) combined with elevated BNP/NT-proBNP level. An elevated BNP/NT-proBNP level highly indicates acute heart failure(AHF).Levosimendan is recommended in many clinical trials of heart failure and Chinese heart failure guidelines. As a result, the investigators form a hypothesis that when patients with AMI combined with elevated BNP/NT-proBNP level are in conditions before AHF, to use levosimendan may reduces the risk of heart failure and improve the outcome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Terminated NCT02151383 - Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure Phase 2
Not yet recruiting NCT03161158 - PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure N/A
Completed NCT02122640 - Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department N/A
Not yet recruiting NCT01211886 - Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU) N/A
Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
Recruiting NCT00512759 - Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study Phase 4
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Enrolling by invitation NCT02258984 - Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial N/A
Completed NCT02141607 - Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock N/A
Completed NCT01870778 - Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF Phase 3
Not yet recruiting NCT03234647 - First In Human Study of the Doraya Catheter for the Treatment of AHF Patients N/A
Not yet recruiting NCT03170219 - Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study Phase 2
Completed NCT02350114 - An Observational Study of the Functional Capacity of Heart Failure N/A
Recruiting NCT01704131 - Levosimendan Pharmacokinetics in Children N/A
Completed NCT00561483 - Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure N/A
Not yet recruiting NCT03302910 - Short Stay Unit vs Hospitalization in Acute Heart Failure Phase 2/Phase 3
Recruiting NCT02728739 - Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients N/A
Withdrawn NCT02299726 - Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study Phase 2
Active, not recruiting NCT01834833 - Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient N/A
Completed NCT01614860 - Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels N/A